Category Archives for "News"

Abattis Announces CannaNUMUS Achievement of Second Milestone

Abattis Announces CannaNUMUS Achievement of Second Milestone FEBRUARY 20, 2018    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that CannaNUMUS Blockchain Inc. (“CannaNUMUS“), a company in which Abattis has a 49% ownership interest, has entered into an agreement to acquire (the “Investment”) a 10% stake in […]

Read More

Abattis awarded a Mitacs grant for R&D of nanoemulsified cannabinoid-rich hemp oil in conjunction with food scientists from the University of British Columbia

Abattis awarded a Mitacs grant for R&D of nanoemulsified cannabinoid-rich hemp oil in conjunction with food scientists from the University of British Columbia FEBRUARY 12, 2018    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the sponsorship of a research study in partnership with Mitacs to explore […]

Read More

Abattis Completes Investment in CannaNUMUS Blockchain and Announces CannaNUMUS’s Achievement of a Significant Milestone

Abattis Completes Investment in CannaNUMUS Blockchain and Announces CannaNUMUS’s Achievement of a Significant Milestone FEBRUARY 8, 2018    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) announces that, further to its news release dated February 1, 2018, it has completed its acquisition of a 49% stake in CannaNUMUS Blockchain Inc. (“CannaNUMUS”), […]

Read More

Abattis Enters Into Definitive Agreement to Acquire 49% Stake In CannaNUMUS Blockchain

Abattis Enters Into Definitive Agreement to Acquire 49% Stake In CannaNUMUS Blockchain FEBRUARY 1, 2018    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into an investment agreement (the “Agreement”) to acquire (the “Acquisition”) a 49% stake in CannaNUMUS Blockchain Inc. (“CannaNUMUS”). CannaNUMUS is […]

Read More

Abattis Partners with Vancouver-Based Craft Brewer to Develop Hemp-Infused, Cannabinoid-Rich, THC-Free Craft Beer

Abattis Partners with Vancouver-Based Craft Brewer to Develop Hemp-Infused, Cannabinoid-Rich, THC-Free Craft Beer JANUARY 22, 2018    |    Abattis Bioceuticals Northern Vine Laboratories Selected to Provide Hemp Extract, and Research & Development and Analytical Testing Services to Develop CBD Beer Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the formation […]

Read More

Abattis Enters Into Definitive Agreement to Acquire Green Tree Therapeutics

Abattis Enters Into Definitive Agreement to Acquire Green Tree Therapeutics JANUARY 11, 2018    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its news releases dated December 22, 2017, it has entered into a definitive agreement (the “Definitive Agreement”) to acquire (the “Acquisition”) […]

Read More